Submucosal vessel detection is critically important in third-space endoscopy because this advanced procedure involves creating a pathway within the layers of the gastrointestinal wall to treat conditions like achalasia, tumors, or gastrointestinal leaks. During this process, endoscopists work near delicate blood vessels embedded in the submucosal layer.
Submucosal vessel detection is critically important in third-space endoscopy because this advanced procedure involves creating a pathway within the layers of the gastrointestinal wall to treat conditions like achalasia, tumors, or gastrointestinal leaks. During this process, endoscopists work near delicate blood vessels embedded in the submucosal layer. If these vessels are accidentally injured, it can lead to severe bleeding, complications, or even life-threatening situations. Accurate identification of submucosal vessels helps the endoscopist navigate safely, avoid vessel injury, and perform the procedure with greater precision.
Artificial intelligence (AI) has the potential to significantly enhance vessel detection during third-space endoscopy. AI algorithms, trained on large datasets of endoscopic images, can automatically identify and outline submucosal vessels in real-time. This reduces the cognitive burden on endoscopists, allowing them to focus on the procedure while relying on AI to highlight high-risk areas. AI can improve safety by offering consistent vessel detection even in challenging conditions like poor visibility or anatomical variations. Additionally, AI could assist less experienced trainees by acting as a "second set of eyes," enhancing their ability to recognize vessels accurately. However, for AI to be effectively integrated into clinical practice, it must demonstrate high accuracy, robustness, and reliability through rigorous testing in real-world scenarios.
Introduction: Artificial intelligence is rapidly transforming healthcare through drug discovery, clinical decision support, remote monitoring, and administrative automation. While AI is widely expected to reduce healthcare costs, this perspective argues that current payment models and...
Introduction: Large frontier AI models such as GPT-5 and Gemini have achieved impressive results across numerous healthcare benchmarks. However, high benchmark scores alone may not reflect real-world clinical reliability. This study systematically evaluated the robustness...
Introduction: Artificial intelligence is rapidly transforming medicine, but its influence extends far beyond healthcare. This JAMA AI Conversations article explores how AI ethics has become a global societal issue, engaging technology leaders, policymakers, healthcare professionals,...
Introduction: Artificial intelligence is rapidly transforming oncology, evolving from image interpretation and pathology analysis to supporting complex clinical decision-making. This perspective argues that AI should enhance the capabilities of oncologists rather than replace their expertise....
Introduction Clinical trial endpoints have traditionally relied on expert human interpretation, particularly for pathology-based outcomes. However, variability between observers, cost, and time remain important limitations. This NEJM AI perspective discusses how artificial intelligence is beginning...
Introduction: As artificial intelligence becomes increasingly integrated into clinical practice, an important question arises: should AI assistants be regulated as medical devices or viewed as evidence-based clinical methodologies? This NEJM AI perspective proposes a new...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.